San Francisco Bay Area HIV Clinical Trials Unit
Official title: San Francisco Bay Clinical Trials Unit (CTU)
Funded at Public Health Foundation Enterprises · NIH-11234302 · Data updated 2026-11-12
Offers clinical trials of new HIV prevention and treatment approaches for people at risk for or living with HIV, especially men who have sex with men and people who inject drugs in the San Francisco Bay Area.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Public Health Foundation Enterprises NIH-funded |
| Lab location | 1 site (City of Industry, United States) |
| Project start | March 2, 2007 |
| Project end | November 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $1,642,142 |
| NIH project number | 5UM1AI069496-20 |
| Project ID | NIH-11234302 on NIH RePORTER |
Who could benefit from this research
✓Could help
People living with HIV or who are at high risk for HIV—particularly men who have sex with men and people who inject drugs—who can travel to Bay Area clinic visits and meet specific trial eligibility.
✕Less likely to help
People who live far from the Bay Area, are unable to attend regular clinic visits, or who do not meet health or age criteria for specific trials may not benefit or be eligible.
What this research studies
You can join trials run by local clinic sites that test new HIV prevention tools and treatment strategies. The unit partners with national networks (ACTG, HPTN, HVTN) and two main Bay Area sites to enroll participants, collect samples, and monitor safety and adherence. Staff work with community groups to support enrollment, retention, and following study procedures, and provide regular clinic visits and testing. The program also trains new HIV researchers so future studies continue improving care.
Why it matters
Potential benefit: Could bring new prevention tools, better treatment options, and improved support for staying on medications to people at risk for or living with HIV.
How similar studies have gone: Previous trials run by the ACTG, HPTN, and HVTN have produced effective HIV treatments and prevention tools, so this work builds on proven network experience.
Where this research is happening
-
Public Health Foundation Enterprises
City of Industry, United States Active
Researchers
- Principal investigator: Buchbinder, Susan — Public Health Foundation Enterprises
- Study coordinator: Buchbinder, Susan
Related research
Other NIH-funded projects on the same topics.
-
San Francisco Bay Area HIV Clinical Trials Unit (CTU) led by top HIV prevention and treatment experts
A large HIV clinical trials program in the San Francisco Bay Area aims to speed prevention and treatment research for people at risk or living with HIV.
-
San Francisco Bay Area HIV Clinical Trials Unit for Prevention and Treatment
A local HIV clinical trials program led by top Bay Area researchers aims to speed up prevention and treatment studies through community-engaged research across ACTG, HPTN, and HVTN networks.
-
Behavioral safety and fentanyl education for people who use stimulants (BSAFE)
A patient-facing program adapts an overdose-prevention approach into a personalized plan plus text reminders to help people who use stimulants avoid unintentional fentanyl exposure.
-
Glutide for Ending Methamphetamine use
A new treatment approach using GLP-1 based therapy aimed at helping adults reduce methamphetamine cravings and use.
-
Long-acting injectable HIV prevention for transgender and non-binary people
This project offers long‑acting injectable HIV prevention (cabotegravir) through a trans-affirming clinic to help transgender and non‑binary people use PrEP more easily.
-
Take Charge: Boosting PrEP awareness and support in the Deep South
This project helps people in the Deep South learn about, start, and stay on PrEP using social media, peer navigators, and mobile support tools.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.